ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

IR

Institute of Rheumatology at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Institute of Rheumatology brings 9 presentations to ACR Convergence 2026 in Orlando. Its program centres on rituximab in treatment-resistant systemic sclerosis and myositis, and on axial spondyloarthritis, from MRI findings to registry-based treatment outcomes. It also covers rheumatoid arthritis risk markers, VEXAS syndrome and urate deposits in children.

OrganizationACR Convergence 2026 Attendance
IR
Institute of Rheumatology
Prague, Czechia
Hospitals and health systems
A specialist rheumatology center and research institute in Prague.
Poster
Sun Nov 8
10:30am–12:30pm

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Institute of Rheumatology

Tell us what you sell and we’ll find the people at Institute of Rheumatology most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction